by EpicentRx | Dec 14, 2022 | 2022, Press Releases
Results from the ROCKET trial, published in the journal Clinical Colorectal Cancer, demonstrate the potential chemoprotective effects of RRx-001 San Diego, Calif., Dec. 14, 2022 – EpicentRx Inc. (“EpicentRx”), a leading-edge, clinical stage biopharmaceutical...
by EpicentRx | Dec 13, 2022 | Blog
San Antonio is home to the Alamo where in 1836, according to the mythic story, a handful of outgunned and outmanned Texans made a final last stand against a besieging Mexican army during the Texas War for Independence. In 2022, almost two centuries after the Battle of...
by EpicentRx | Dec 8, 2022 | Blog
The 2022 Inflammasome Summit is in the books—well, more accurately, in the notebooks of the in-person attendees who took copious notes. TBH, we haven’t witnessed scribbling like that since freshman history class. Which makes sense because as first in-person...
